loadpatents
Patent applications and USPTO patent grants for Dave; Kandarp Maheshkumar.The latest application filed is for "parenteral dosage form of diltiazem".
Patent | Date |
---|---|
Parenteral dosage form of diltiazem Grant 11,241,379 - Kumar , et al. February 8, 2 | 2022-02-08 |
Parenteral dosage form of norepinephrine Grant 11,166,923 - Thummar , et al. November 9, 2 | 2021-11-09 |
Parenteral Dosage Form Of Diltiazem App 20200246254 - Kind Code | 2020-08-06 |
Ready-to-administer Solution Of Fentanyl Citrate App 20190117560 - KUMAR; Samarth ;   et al. | 2019-04-25 |
Ready-to-administer solution of fentanyl citrate Grant 10,206,872 - Kumar , et al. Feb | 2019-02-19 |
Parenteral Dosage Form Of Norepinephrine App 20180140563 - THUMMAR; Rakesh ;   et al. | 2018-05-24 |
Stable Infusion Dosage Form Of Morphine App 20180064703 - KUMAR; Samarth ;   et al. | 2018-03-08 |
Ready-to-administer Solution Of Fentanyl Citrate App 20160367476 - KUMAR; Samarth ;   et al. | 2016-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.